These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4715004)

  • 1. Quinazolines as inhibitors of dihydrofolate reductase. 1.
    Ashton WT; Walker FC; Hynes JB
    J Med Chem; 1973 Jun; 16(6):694-7. PubMed ID: 4715004
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.
    Fukunaga JY; Hansch C; Steller EE
    J Med Chem; 1976 May; 19(5):605-11. PubMed ID: 1271401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinazolines as inhibitors of dihydrofolate reductase. 2.
    Hynes JB; Ashton WT
    J Med Chem; 1974 Sep; 17(9):1023-5. PubMed ID: 4213339
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
    Ghose AK; Crippen GM
    J Med Chem; 1983 Jul; 26(7):996-1010. PubMed ID: 6864738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1984 Jul; 27(7):901-14. PubMed ID: 6737433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1982 Aug; 25(8):892-9. PubMed ID: 7120278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
    Battershell C; Malhotra D; Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):812-8. PubMed ID: 7277385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of dihydrofolate reductase inhibitors.
    Bowden K; Harris NV; Watson CA
    J Chemother; 1993 Dec; 5(6):377-88. PubMed ID: 8195829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
    Harris NV; Smith C; Bowden K
    J Med Chem; 1990 Jan; 33(1):434-44. PubMed ID: 2404122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazolines as inhibitors of dihydrofolate reductase. 3. Analogs of pteroic and isopteroic acids.
    Hynes JB; Buck JM; D'Souza L; Freisheim JH
    J Med Chem; 1975 Dec; 18(12):1191-4. PubMed ID: 811798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts.
    Hynes JB; Patil SA; Hagan RL; Cole A; Kohler W; Freisheim JH
    J Med Chem; 1989 Apr; 32(4):852-6. PubMed ID: 2704031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pteridines. 41. Synthesis and dihydrofolate reductase inhibitory activity of some cycloalka[g]pteridines.
    Taylor EC; Berrier JV; Coccuzza AJ; Kobylecki R; McCormack JJ
    J Med Chem; 1977 Sep; 20(9):1215-8. PubMed ID: 411935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminiquinazolines and related compounds.
    Richter WE; McCormack JJ
    J Med Chem; 1974 Sep; 17(9):943-7. PubMed ID: 4213189
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
    Rosowsky A; Mota CE; Queener SF; Waltham M; Ercikan-Abali E; Bertino JR
    J Med Chem; 1995 Mar; 38(5):745-52. PubMed ID: 7877140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative biochemistry of dihydrofolate reductase.
    Burchall JJ
    Ann N Y Acad Sci; 1971 Nov; 186():143-52. PubMed ID: 4943573
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
    Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.